A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.
The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.
Another natural method that may help you find relief from environmental factors behind your post-nasal drip is by inhaling steam (safely!), Dr. Mayerhoff says. He says you can do this by boiling a bit ...
PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment isn’t ...
People in Phoenix suffering from severe depression now have a Ketamine-derived nasal spray available for treatment.
This nasal spray vaccine can be self-administered or given by a caregiver, potentially increasing vaccination rates and accessibility.
Emergency overdose reversal kits have been installed at some public facilities in Durango. The kits contain naloxone, a nasal spray that can be used to help treat an opioid overdose. They also include ...
A major trial in frontotemporal dementia patients has found that oxytocin can help improve symptoms of apathy. A new study led by Western researchers suggests that frequent treatment with intranasal o ...
The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a treatment for depression. A clinic in Denver is looking to help those ...
Half of Austria is sick in bed, many are plagued by colds, coughs and swollen mucous membranes. A cold is naturally ...
ALK-Abello’s expanding portfolio in Europe is expected to gain momentum as these new products reach the market, with Jefferies forecasting a compound annual growth rate of 14% over five years—higher ...
Piles of snow continue to melt, leaving behind a muddy mess. One allergist says there is always the concern for mold whenever there’s moisture.